NCT05982236

The Psychological and Social Impact of PCOS

University Hospital, Lille·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
Questionnaire
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University Hospital, Lille
Location
Lille, France
Timeline & enrollment
Phase
N/A
Start date
Jul 07, 2023
End date
Apr 07, 2024
Enrollment
100 participants
Primary outcome

Assessment to the PCOSQOL questionnaire score according to predefined factors (age, BMI, socio-professional category, delay in diagnosis of PCOS, infertility, hyperandrogenism, parity, history of anxiety and depression, cycle disorders).

Summary

The aim of the study is to assess the association between the quality of life of patients
 with PCOS and various factors (age, BMI, socio-professional category, delay in diagnostic of
 PCOS, infertility, hyperandrogenism, parity, history of anxiety and depression, cycles
 disorders). This study will be proposed to patients known to have PCOS, during a follow-up
 consultation or a visit to a day hospital in the Gynaecology Department and/or a consultation
 in the Reproductive Medicine Department. No-objection forms will be collected at the same
 time. A link will be sent by e-mail to the patient to access the online questionnaire on the
 WEPI software and complete it after the consultation. Responses to the questionnaire will be
 collected progressively and stored in a secure RedCAP file.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05982236
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05982236 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Lille and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.